Pamufetinib mesylate
Pamufetinib mesylate (TAS-115) is a dual VEGFR and c-Met inhibitor used in cancer research. It has been investigated in preclinical studies for its potential in treating solid tumors and has shown activity in both in vitro cellular assays and in vivo animal models.
Product Specifications
CAS Number
1688673-09-7
Product Name Alternative
CMet, c-Met, c-Met/HGFR, cMet/HGFR, HGFR, rVEGFR2, rMET, TAS 115 Mesylate, TAS115 mesylate, TAS-115 mesylate, TAS-115 methanesulfonate, VEGFR
Field of Research
Cardiovascular Research, Signal Transduction
Purity
98.91% (May vary between batches)
Solubility
DMSO:60 mg/mL (97.61 mM)
Smiles
O=C (NC) C1=CC=2C (=NC=CC2OC3=CC=C (C=C3F) NC (=S) NC (=O) CC=4C=CC=CC4) C=C1OC.O=S (=O) (O) C
Molecular Formula
C28H27FN4O7S2
Molecular Weight
614.67
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog